As an early Christmas present for some, Chile and Mexico began immunizations on Thursday after emergency approval was granted for the Pfizer / BioNTech vaccine. But in Brazil, where the death toll in Covid-19 is much higher, life-saving inoculation could be within months – the country’s health ministry announced last week that vaccinations would begin in February 2021.
Because Brazil has a strong national vaccination history, she says there is a widespread expectation that Brazilians will have a regional advantage in fighting the pandemic.
“Brazil has always been the leader in the implementation of new vaccines. We are able to achieve high vaccine coverage, even if it is a continental country with very different regions, such as São Paulo with a high population density and Amazonas with huge distances, ( and) an indigenous population, “she said.
“People expected the Brazilian vaccination program to start earlier,” she said. But “other countries in America that have already prepared are starting vaccination, and Brazil is lagging behind.”
With more than 7.4 million people diagnosed with Covid-19 in Brazil and new variants of the virus appearing abroad, there is little reason to believe the pandemic is diminishing – a statement Bolsonaro has repeatedly made. this year, even as cases continued to grow. in the country. Only the US and India have reported more coronavirus infections than Brazil.
The Brazilian president also made headlines last week, with a bizarre attempt to sow doubts about the potential side effects of the Pfizer vaccine. “If you become an alligator, this is your problem,” he warned. “If you become Superman or you think your beard as a woman or a man’s voice gets strong, I have nothing to do with it … or, worse, you interfere with people’s immune systems.”
Pfizer did not respond to CNN’s request for comment.
Domingues believes that the Brazilian federal government was caught unprepared to use the Pfizer / BioNTech vaccine after casting support for a vaccine candidate from Oxford University and AstraZeneca, who collaborated with the local Fiocruz foundation. According to a statement released last week by the Ministry of Health, Brazil has agreed to purchase more than 100 million doses of that vaccine, which remains under development.
Meanwhile, fears persist over the influence of politics on the process, after a year of bitter clashes between Bolsonaro and state governors over the country’s pandemic response.
The president made no secret of preferring the Oxford / AstraZeneca vaccine instead of a vaccine developed by Chinese manufacturer Sinovac Biotech, which is supported by the state of Sao Paulo and is developing locally with the Brazilian laboratory Butantan Institute.
ANVISA and the Brazilian Ministry of Health did not respond to requests for comment.
Reporting contributed by Tatiana Arias, Jennifer Z. Deaton, Natalie Gallon and Stefano Pozzebon.